Security key
629444209
NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (NRXP)
CUSIP: 629444209
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 3,956,630
- Total 13F value
- $13,043,325
- Share change
- +962,262
- SEC-reported price per share
- $3.30
- Number of holders
- 24
- Value change
- +$3,167,783
- Number of buys
- 16
- Number of sells
- 8
- Shares outstanding
- 35,443,612
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
24
Top holders
10
NRXP full security history
Ownership snapshot
Full 13F holder table
NRX Pharmaceuticals, Inc. SEC filings
NRX Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of NRXP - NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
B Group, Inc.
Disclosed value leader
B Group, Inc.
Comparable rows
15/15
Latest evidence
18 Aug 2025
3/4/5
13D/G
13F
Lead comparable stake: 13%
13D/G row: B Group, Inc.
Showing 1-6 of 15 holder rows.
Quick read
B Group, Inc. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens B Group, Inc.'s linked filing trail.
Comparable ownership
Top 5
B Group, Inc.
13%
Anson Funds Management LP
4.5%
VANGUARD GROUP INC
1.3%
AdvisorShares Investments LLC
0.74%
GEODE CAPITAL MANAGEMENT, LLC
0.49%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| B Group, Inc. |
3/4/5
13D/G
10%+ Owner · The B Group, Inc.
|
13%
from 13D/G
|
$8,820,000
3,000,000 shares
|
— | 18 Aug 2025 |
| Anson Funds Management LP |
13F
Company
|
4.5%
|
$5,232,219
1,604,975 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$1,474,091
452,175 shares
|
— | 30 Jun 2025 |
| AdvisorShares Investments LLC |
13F
Company
|
0.74%
|
$859,978
263,797 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.49%
|
$561,596
172,255 shares
|
— | 30 Jun 2025 |
| UBS Group AG |
13F
Company
|
0.34%
|
$396,442
121,608 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
3,956,630
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
25
Q3 2025 holders
24
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|